In vivo amelioration of endogenous antitumor autoantibodies via low-dose P4N through the LTA4H/activin A/BAFF pathway” Y-L Lin, N-M Tsai, C-H Hsieh, S-Y Hoa, J Chang, H-Y Wu, M-H Hsu
Proc. Natl. Acad. Sci.
Y-L Lin, N-M Tsai, C-H Hsieh, S-Y Hoa, J Chang, H-Y Wu, M-H Hsu, C-C Chang, K-W Liao, T L Jackson, D
2020-10-28